Tone B. Aabrekk
Tonsberg, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial.
Journal: Journal of Crohn's & colitis
Published: August 06, 2026
Anxiety and depression in newly diagnosed patients with inflammatory bowel disease (the IBSEN III study) compared with the general population in Norway.
Journal: Journal of Crohn's & colitis
Published: March 13, 2026
Bacterial clusters are associated with the risk of severe disease progression in inflammatory bowel disease irrespective of conventional disease categories.
Journal: Microbiome research reports
Published: November 10, 2025
Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study.
Journal: Inflammatory bowel diseases
Published: October 29, 2025
Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III study.
Journal: Digestive diseases and sciences
Published: September 08, 2025
Predicting severe inflammatory bowel disease: a risk matrix model based on the IBSEN III inception cohort.
Journal: Scandinavian journal of gastroenterology
Published: June 08, 2025
Simultaneous profiling of the blood and gut T and B cell repertoires in Crohn's disease and symptomatic controls illustrates tissue-specific alterations in the immune repertoire of individuals with Crohn's disease.
Journal: Frontiers in immunology
Published: May 30, 2025
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype.
Journal: Journal of Crohn's & colitis
Published: April 19, 2025
Habitual intake of macronutrients and fermentable oligo-, di-, monosaccharides and polyols is not associated with irritable bowel syndrome-like symptoms in inflammatory bowel disease.
Journal: Clinical nutrition ESPEN
Published: December 04, 2024
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort).
Journal: Inflammatory bowel diseases
Published: November 14, 2024
Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort.
Journal: Inflammatory bowel diseases
Published: October 07, 2024
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study).
Journal: Journal of Crohn's & colitis
Published: August 30, 2024
Last Updated: 09/26/2026